arrow
M

Monica Patten

University of Hamburg
H指数:28
被引数:5,049

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy

时间趋势、患者特征及医院病例量对梗阻性肥厚型心肌病经冠状动脉间隔消融术和间隔心肌切除术治疗结果的影响

2025-10-090
OA
Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants

遗传性转甲状腺素蛋白相关淀粉样变性正在进行的观察性研究: 前3167名参与者的基线报告

2024-10-170
OAAI
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)

欧洲心脏病学会 (ESC) 室性心律失常患者管理和预防心脏猝死工作组制定的2022 ESC室性心律失常患者管理和预防心脏猝死指南欧洲儿科和先天性心脏病协会 (AEPC) 认可

2022-08-261.1K
PRE
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy (vol 11, e11115, 2019)
2022-08-083
OA
Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology

遗传性甲状腺素运载蛋白相关的淀粉样变性在无明显病因的多发性神经病和心肌病中很常见

2021-10-1617
OAAI
CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy

肥厚型心肌病患者的CMR特征追踪应变模式及其与循环心脏生物标志物的关联

2021-03-2924
OAAI
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS)
2021-03-1632
PREAI
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long Term Outcome

肥厚型心肌病患者心房颤动的消融: 治疗策略,连续房性心动过速的特征和长期结果

2021-02-0236
OAAI
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)
2020-04-2742
PREAI
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy
2019-11-0395
OAAI
Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis
2019-06-2635
OAAI
Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive Male Triathletes With Normal Ejection Fraction
2019-06-2525
OAAI